D.BSRA-240502ALT-1

D.BSRA - EI_Fc-Engineered

samples-publish2024-06-04-D.BSRA.xlsx

D.BSRA-240502ALT-1

BSRA-Macrophage

MRA_MBL-FcEngineered-EI.xlsx

https://immport.org/shared/study/SDY2541

ea17dee57c0ec75bd0a7890fe1c1d0e9

MD5

BAC-220920ALT-1; TIS-240502ALT-1; AB-220920ALT-1; AB-220921ALT-1; AB-220920ALT-2; AB-220920ALT-3; AB-220920ALT-4; AB-220920ALT-5; AB-220920ALT-6; AB-220920ALT-7; AB-220920ALT-8; AB-220920ALT-9; AB-220920ALT-10; AB-220920ALT-11; AB-220920ALT-12; AB-220920ALT-13; AB-220920ALT-14; AB-220920ALT-15; AB-220920ALT-16; AB-220920ALT-17; AB-220920ALT-18; AB-220920ALT-19; AB-220920ALT-20; AB-220920ALT-21; AB-220920ALT-22; AB-220920ALT-23; AB-220920ALT-24; AB-220920ALT-25; AB-220920ALT-26; AB-220920ALT-27; AB-220920ALT-28; AB-220920ALT-29; AB-220920ALT-30; AB-220920ALT-31; AB-220920ALT-32; AB-220920ALT-33; AB-220920ALT-34; AB-220920ALT-35; AB-220920ALT-36; AB-220920ALT-37; AB-220920ALT-38; AB-220920ALT-39; AB-220920ALT-40; AB-220920ALT-41; AB-220920ALT-42; AB-220920ALT-43; AB-220920ALT-44; AB-220920ALT-45; AB-220920ALT-46; AB-220920ALT-47; AB-220920ALT-48; AB-220920ALT-49; AB-220920ALT-50; AB-220920ALT-51; AB-220920ALT-52; AB-220921ALT-2

Eddie Irvine

2018-04-15T0:0:0+0000

https://fairdomhub.org/sops/729

Macrophage Restriction Assay

mCherry for constitutive expression, GFP under anhydrotetracycline inducible promoter

GFP, mCherry

H37Rv Mtb Live/dead Reporter

1.0x10^6 bacteria per mL of blood

Human monocyte-derived macrophages (MDMs)

N/A

N/A

N/A

N/A

N/A

Fixed and analyzed 3 days post-infection, with additional 16hr post-anhydrotetracycline addition

Columbus Image Data Storage and Analysis System

Revvity

Anhydrotetracycline added at 200 ng/mL to induce GFP expression; monoclonal antibody at 50μg/mL in R10 media without phenol

help Creators and Submitter
Creators
Not specified
Submitter
Activity

Views: 35

Created: 6th Jun 2024 at 15:05

help Tags

This item has not yet been tagged.

help Attributions

None

Powered by
(v.1.15.2)
Copyright © 2008 - 2024 The University of Manchester and HITS gGmbH